Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 327-335

  Ouatu Lascar, R ^a   Fitzgerald, R C ^a   Triadafilopoulos, G ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; LANSOPRAZOLE; VILLIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS MOTILITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS;

EID: 0032782622     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900327     Document Type: Article

References (39)

1. N.R. Barrett The lower esophagus lined by columnar epithelium Surgery 41 1957 881 894
2. S.J. Spechler R.J. Goyal The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett Gastroenterology 110 1996 614 621
3. R.C. Haggit Barrett's esophagus, dysplasia and adenocarcinoma Hum Pathol 25 1994 982 993
4. W.J. Blot S.S. Devesa R.W. Kneller J.F. Fraumeni Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
5. R.C. Fitzgerald G. Triadafilopoulos Recent developments in the molecular characterization of Barrett's esophagus Dig Dis 16 1998 63 80
6. W.H. Chow W.D. Finkle J.K. Mclaughlin H. Frankl H.K. Ziel J.F. Fraumeni Jr The relationship of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 1995 474 477
7. S. Gore L.J. Healy R. Sutton I.A. Eyre-Brooke M.W.L. Gear N.A. Shepherd S.P. Wilkinson Regression of columnar-lined (Barrett's) oe-sophagus with continuous omeprazole therapy Aliment Pharma-col Ther 7 1993 623 628
8. G.W.B. Clark T.R. Demeeester Surgical management of Barrett's esophagus Ann Chir Gynaecol 1995 84139 84144
9. R.E. Sampliner Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus Am J Gastroenterol 89 1994 1844 1848
10. P.M. Sagar R. Ackroyd K.B. Hosie J.E. Patterson C.J. Stoddard A.N. Kingsnorth Regression and progression of Barrett's esopha-gus after antireflux therapy Br J Surg 82 1995 806 810
11. C.J. Lightdale Photodynamic therapy: a new light on Barrett's esophagus Gastrointest Endosc 42 1995 96 98
12. B.F. Overholt M. Panjehpour Photodynamic therapy for Barrett's esophagus: clinical update Am J Gastroenterol 91 1996 1719 1723
13. R.E. Sampliner B. Fennerty H.S. Garewal Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagula-tion: preliminary results Gastrointest Endosc 44 1996 532 535
14. R.C. Fitzgerald M.B. Omary G. Triadafilopoulos Dynamic effects of acid on Barrett's esophagus: an ex vivoproliferation and differen-tiation model J Clin Invest 98 1996 2120 2128
15. K.C. Tremble A. Pryde R.C. Heading Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitiv-ity in GERD Gut 37 1995 7 12
16. R. Ouatu-Lascar G. Triadafilopoulos Complete elimination of reflux symptoms does not guarantee normalization of intraesoph-ageal acid reflux in patients with Barrett's esophagus Am J Gastroenterol 93 1998 711 716
17. G. Triadafilopoulos M. Kaczynska M. Iwane Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus Am J Gastroenterol 91 1996 65 74
18. W.M. Weinstein A.F. Ippoliti The diagnosis of Barrett's esophagus: goblets, goblets, goblets Gastrointest Endosc 44 1996 91 95
19. K.J. Lewin R.H. Riddell W.M. Weinstein Barrett's-associated dyspla-sia 1st ed K.J. Lewin R.H. Riddell W.M. Weinstein Gastrointestinal pathology and its clinical implications Volume 1 1992 Igaku-Shoin New York 422 426
20. C. Emde A. Garner A.L. Blum Technical aspects of intraluminal pH-metry in man: current status and recommendations Gut 28 1987 1177 1188
21. J.E. Richter T.R. Demeester W.C. Wu F.W. Sinclair C. Schan L.A. Bradley Normal 24-hr ambulatory esophageal pH values: influence of study center, pH electrode, age and gender Dig Dis Sci 37 1992 849 856
22. S.B. Benjamin J.E. Richter C.M. Cordova T.E. Knuff D.O. Castell Prospective manometric evaluation with pharmacologic provoca-tion of patients with suspected esophageal motility dysfunction Gastroenterology 84 1983 893 901
23. R.C. Fitzgerald M.B. Omary G. Triadafilopoulos Acid modulation of HT-29 cell growth and differentiation. An in vitro model for Barrett's esophagus J Cell Sci 110 1997 663 671
24. S. Kumble M.B. Omary L.F. Fajardo G. Triadafilopoulos Multifocal heterogeneity in villin and Ep-cam expression in Barrett's esopha-gus Int J Cancer 66 1996 48 54
25. M.R. Gray P.A. Hall J. Nash B. Ansari P.L. Lane A.N. Kingsworth Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization Gastroenterology 103 1992 1769 1776
26. A. Zweibaum M. Pinto G. Chevalier E. Dussaulx N. Triadou B. Lacroix K. Haffen J.-L. Brun M. Rousset Enterocytic differentiation of a subpopulation of the human colon tumor line HT-29 selected for growth in sugar-free medium and its inhibition by glucose J Cell Physiol 122 1985 21 29
27. E.M. Pringault M. Arpin A. Garcia A. Findori D.A. Louvard Human villin cDNA clone to investigate the dif ferentiation of intestinal and kidney cells in vivo EMBO J 5 1986 3119 3124
28. N. Munoz M. Lipkin M. Crespi J. Wharendorf A. Grassi S. Lu Proliferation abnormalities of the oesophageal epithelium of Chinese populations at high and low risk for oesophageal cancer Int J Cancer 36 1985 187 189
29. PA Hall DA Levison AL Woods CC Yu DB Kellock JA Watkins DM Barnes Ce Gillett R Camplejohn R Dover NH Waseem DP Lane Proliferating cell nuclear antigen (PCNA) immuno-localization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms J Pathol 162 1990 285 294
30. A.M. Kingnorth W.E. Russell P.P. Mccann K.A. Diekema J.S. Ross R.A. Malt Inhibition of ornithine decarboxylase with alpha-difluoromethyl-ornithine reduces incidence of dimethyl-hydrazine-induced colon tumors in mice Cancer Res 43 1983 2545 2549
31. D.A. Katzka D.O. Castell Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus Am J Gastroenterol 89 1994 989 991
32. A. Malesci V. Savarino P. Zentilin M. Belicchi G. Sandromela G. Lapertosa P. Bocchia G. Ronchi M. Franceschi Partial regres-sion of Barrett's esophagus by long-term therapy with high-dose omeprazole Gastrointest Endosc 44 1996 700 705
33. E.C. Klinkenberg-Knol S.G.M. Meuwissen Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manom-etry in patients with reflux disease, resistant to treatment with omeprazole Aliment Pharmacol Ther 4 1990 485 495
34. P. Kasapidis E. Xynos A. Mantides E. Chrysos M. Demonakou N. Nicolopoulos F.S. Vessilakis Dif ferences in manometry and 24-hr ambulatory pH-metry between patients with and without endoscopic or histologic esophagitis in gastroesophageal reflux disease Am J Gastroenterol 88 1993 1893 1899
35. P. Sharma R.E. Sampliner E. Camargo Normalization of esopha-geal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus Am J Gastroenterol 92 1997 582 585
36. W.M. Weinstein D.A. Lieberman K.J. Lewin J. Weber M.L. Beger A.F. Ippolitti Omeprazole-induced regression of Barrett's esopha-gus: a two-year, randomized, controlled, double-blind trial (abstr) Gastroenterology 110 1996 A294
37. G.J. Wiener T.M. Morgan J.B. Copper W.C. Wu D.O. Castell J.E. Richter Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters Dig Dis Sci 33 1988 1127 1133
38. F. Johnsson B. Joelsson Reproducibility of 24-hour ambulatory pH monitoring Gut 29 1988 886 889
39. G. Champion J.E. Richter M.F. Vaezi S. Singh R. Alexander Duodeno-gastric reflux: relationship to pH and importance in Barrett's esophagus Gastroenterology 107 1994 747 754